Search Results - "Nahar, Kazi"

Refine Results
  1. 1
  2. 2
  3. 3

    Effects of Systematic Shortening of Noncovalent C8 Side Chain on the Cytotoxicity and NF-κB Inhibitory Capacity of Pyrrolobenzodiazepines (PBDs) by Corcoran, David B, Lewis, Thomas, Nahar, Kazi S, Jamshidi, Shirin, Fegan, Christopher, Pepper, Chris, Thurston, David E, Rahman, Khondaker Miraz

    Published in Journal of medicinal chemistry (28-02-2019)
    “…The systematic shortening of the noncovalent element of a C8-linked pyrrolobenzodiazepine (PBD) conjugate (13) led to the synthesis of a 19-member library of…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report by Hultin, Sebastian, Nahar, Kazi, Menzies, Alexander M, Long, Georgina V, Fernando, Suran L, Atkinson, Victoria, Cebon, Jonathan, Wong, Muh Geot

    Published in BMC nephrology (07-09-2020)
    “…Immune checkpoint inhibitors (ICI) have become the standard of care in many oncological conditions but are associated with a spectrum of renal immune-related…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Noncytotoxic Pyrrolobenzodiazepine–Ciprofloxacin Conjugate with Activity against Mycobacterium tuberculosis by Picconi, Pietro, Jeeves, Rose, Moon, Christopher William, Jamshidi, Shirin, Nahar, Kazi S, Laws, Mark, Bacon, Joanna, Rahman, Khondaker Miraz

    Published in ACS omega (17-12-2019)
    “…The development of new antitubercular agents for the treatment of infections caused by multidrug-resistant (MDR) Mycobacterium tuberculosis is an urgent…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    C8-Linked Pyrrolobenzodiazepine Monomers with Inverted Building Blocks Show Selective Activity against Multidrug Resistant Gram-Positive Bacteria by Andriollo, Paolo, Hind, Charlotte K, Picconi, Pietro, Nahar, Kazi S, Jamshidi, Shirin, Varsha, Amrit, Clifford, Melanie, Sutton, J. Mark, Rahman, Khondaker Miraz

    Published in ACS infectious diseases (09-02-2018)
    “…Antimicrobial resistance has become a major global concern. Development of novel antimicrobial agents for the treatment of infections caused by multidrug…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Primary Pericardial Sarcoma with Right Atrial Invasion and Multiple Bilateral Pulmonary Metastases in a Patient with Hereditary Nonpolyposis Colorectal Cancer by Lee, Adrian, Nahar, Kazi, Oh, Lawrence, Wong, Eugene, Clarke, Stephen J.

    Published in Case reports in oncological medicine (01-01-2016)
    “…Primary tumours originating from the pericardium are extremely rare. Previous studies have reported that these tumours account for only 6.7–12.8% of all…”
    Get full text
    Journal Article
  15. 15

    Triaryl Benzimidazoles as a New Class of Antibacterial Agents against Resistant Pathogenic Microorganisms by Picconi, Pietro, Hind, Charlotte, Jamshidi, Shirin, Nahar, Kazi, Clifford, Melanie, Wand, Matthew E, Sutton, J. Mark, Rahman, Khondaker Miraz

    Published in Journal of medicinal chemistry (27-07-2017)
    “…A new class of nontoxic triaryl benzimidazole compounds, derived from existing classes of DNA minor groove binders, were designed, synthesized, and evaluated…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Abstract 9: Effect of C8-side chain on the cytotoxicity and NF-kB inhibitory capacity of pyrrolobenzodiazepines by Corcoran, David B., Lewis, Thomas, Nahar, Kazi S., Fegan, Christopher, Pepper, Chris, Thurston, David E., Rahman, Khondaker Miraz

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Abstract Pyrrolobenzodiazepines (PBDs) have long been of interest in chemotherapeutic research as potential clinical agents. Recently, the conjugation of…”
    Get full text
    Journal Article
  18. 18

    Abstract A125: Fragment-based approach to develop small-molecule STAT3 transcription factor inhibitors by Nahar, Kazi S., Jamshidi, Shirin, Thurston, David E., Rahman, Khondaker Miraz

    Published in Molecular cancer therapeutics (01-01-2018)
    “…Abstract Oncogenic transcription factors are an increasingly important target for anticancer therapies, as inhibition could allow the “reprogramming” of tumor…”
    Get full text
    Journal Article
  19. 19
  20. 20